Wednesday, June 11, 2008

Daiichi Sankyo to buy out Ranbaxy: US$ 2.7 to 3.7 bn

Japanese major Daiichi Sankyo is all set to buy out Ranbaxy, paying anything between 30 per cent and 50 per cent premium for the pharmaceutical company. It would mean the complete exit of Ranbaxy promoters from the company..

More on Daiichi Sankyo to buy out Ranbaxy: US$ 2.7 to 3.7 bn

No comments: